Back to Journals » Psoriasis: Targets and Therapy » Volume 5
Review
![Noteworthy comment: Apremilast is a new drug for the European market.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Update on the treatment of psoriasis and psoriatic arthritis – role of apremilast
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
16,685 | Dovepress* | 14,658+ | 1,940 | 16,598 | |
PubMed Central* | 2,027 | 273 | 2,300 | ||
Totals | 16,685 | 2,213 | 18,898 | ||
*Since 7 September 2015 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 1 | 0 | 0 | 0 | 1 |
View citations on PubMed Central and Google Scholar